Sign Up Today and Learn More About PackGene Biotech Stock
Invest in or calculate the value of your shares in PackGene Biotech or other pre-IPO companies through EquityZen's platform.
PackGene Biotech Stock (PACB)
PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.
About PackGene Biotech Stock
Founded
2014
Industries
Software, Artificial Intelligence, Data and Analytics
PackGene Biotech Press Mentions
Stay in the know about the latest news on PackGene Biotech
After-hours movers: lululemon athletica, Argan and more
streetinsider • Mar 27, 2025
Portage Biotech (PRTG) Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
streetinsider • Feb 13, 2025
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
globenewswire • Feb 12, 2025
A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefining What's Possible in Gene Therapy with Help from Weill Cornell Medicine
prnewswire • Jan 08, 2025
PackGene Biotech, Inc. on LinkedIn: #research #genetics #science
linkedin • May 24, 2024
PackGene Biotech Management
Leadership team at PackGene Biotech
Founder, Chairman and General Manager
Huapeng Li
Join now and verify your accreditation status to gain access to:
- PackGene Biotech Current Valuation
- PackGene Biotech Stock Price
- PackGene Biotech Management
- Available deals in PackGene Biotech and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PackGene Biotech Cap Table and Funding History by Share Class and Liquidity Preferences
- PackGene Biotech Revenue and Financials
- PackGene Biotech Highlights
- PackGene Biotech Business Model
- PackGene Biotech Risk Factors
- PackGene Biotech Research Report from SACRA Research
Trading PackGene Biotech Stock
How to invest in PackGene Biotech stock?
Accredited investors can buy pre-IPO stock in companies like PackGene Biotech through EquityZen funds. These investments are made available by existing PackGene Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PackGene Biotech stock?
Shareholders can sell their PackGene Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
